Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Curr Cardiol Rev ; 13(3): 189-198, 2017.
Article in English | MEDLINE | ID: mdl-28093987

ABSTRACT

BACKGROUND: Heart type fatty acid protein (HFABP) is a cytosolic protein released early after acute coronary syndrome (ACS) even in the absence of myocardial necrosis. OBJECTIVES: The purpose of this systematic review was to determine whether HFABP levels in patients with suspected, or confirmed ACS, improve risk stratification when added to established means of risk assessment. METHODS: We searched Medline, Pubmed and Embase databases from inception to July 2015 to identify prospective studies with suspected or confirmed ACS, who had HFABP measured during the index admission with at least 1 month follow up data. A prognostic event was defined as allcause mortality or acute myocardial infarction (AMI). RESULTS: 7 trials providing data on 6935 patients fulfilled inclusion criteria. There were considerable differences between studies and this was manifest in variation in prognostic impact of elevated HFABP(Odds ratio range 1.2-15.2 for death). All studies demonstrated that HFABP provide unadjusted prognostic information and in only one study this was negated after adjusting for covariates. A combination of both negative troponin and normal HFABP conferred a very low event rate. No study evaluated the incremental value of HFABP beyond that of standard risk scores. Only one study used a high sensitive troponin assay. CONCLUSION: There was marked heterogeneity in prognostic impact of HFABP in ACS between studies reflecting differences in sampling times and population risk. Prospective studies of suspected ACS with early sampling of HFABP in the era of high sensitivity troponin are necessary to determine the clinical value of HFABP. HFABP should not currently be used clinically as a prognostic marker in patients with suspected ACS.


Subject(s)
Acute Coronary Syndrome/metabolism , Fatty Acid Binding Protein 3/metabolism , Biomarkers/metabolism , Humans , Prognosis
2.
J Pediatr ; 153(6): 758-63, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18589442

ABSTRACT

OBJECTIVE: To develop reference intervals (RIs) for sweat chloride and sodium in healthy children, adolescents, and adults. STUDY DESIGN: Healthy, unrelated subjects aged from 5 to >50 years and subjects who were pancreatic insufficient with cystic fibrosis (CF) were recruited. Sweat collection was performed on all subjects with the Wescor Macroduct system. Sweat electrolytes were analyzed with direct ion selective electrodes. DeltaF508 mutation analysis was performed on the healthy subjects >/=15 years old. RESULTS: A total of 282 healthy and 40 subjects with CF were included for analysis. There was no overlap of sweat chloride between the group with CF and the group without CF, but there was some overlap of sweat sodium. Sweat chloride increased with age, with the rate of increase slowing progressively to zero after the age of 19 years. The estimated median (95% RI) for sweat chloride were: 5 to 9 years, 13 mmol/L (1-39 mmol/L); 10 to 14 years, 18mmol/L (3-47 mmol/L); 15 to 19 years, 20 mmol/L (3-51mmol/L); and 20+ years 23 mmol/L (5-56mmol/L). CONCLUSIONS: We have successfully developed the age-related RI for sweat electrolytes, which will be useful for clinicians interpreting sweat test results from children, adolescents, and adults.


Subject(s)
Aging/metabolism , Chlorides/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/diagnosis , Cystic Fibrosis/metabolism , Sodium/metabolism , Sweat/chemistry , Adolescent , Adult , Aged , Child , Child, Preschool , Cohort Studies , Cystic Fibrosis/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/isolation & purification , Female , Humans , Male , Middle Aged , Mutation , Reference Values , Young Adult
3.
J Appl Physiol (1985) ; 105(1): 7-13, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18467543

ABSTRACT

We determined the effect of coingestion of caffeine (Caff) with carbohydrate (CHO) on rates of muscle glycogen resynthesis during recovery from exhaustive exercise in seven trained subjects who completed two experimental trials in a randomized, double-blind crossover design. The evening before an experiment subjects performed intermittent exhaustive cycling and then consumed a low-CHO meal. The next morning subjects rode until volitional fatigue. On completion of this ride subjects consumed either CHO [4 g/kg body mass (BM)] or the same amount of CHO + Caff (8 mg/kg BM) during 4 h of passive recovery. Muscle biopsies and blood samples were taken at regular intervals throughout recovery. Muscle glycogen levels were similar at exhaustion [ approximately 75 mmol/kg dry wt (dw)] and increased by a similar amount ( approximately 80%) after 1 h of recovery (133 +/- 37.8 vs. 149 +/- 48 mmol/kg dw for CHO and Caff, respectively). After 4 h of recovery Caff resulted in higher glycogen accumulation (313 +/- 69 vs. 234 +/- 50 mmol/kg dw, P < 0.001). Accordingly, the overall rate of resynthesis for the 4-h recovery period was 66% higher in Caff compared with CHO (57.7 +/- 18.5 vs. 38.0 +/- 7.7 mmol x kg dw(-1) x h(-1), P < 0.05). After 1 h of recovery plasma Caff levels had increased to 31 +/- 11 microM (P < 0.001) and at the end of the recovery reached 77 +/- 11 microM (P < 0.001) with Caff. Phosphorylation of CaMK(Thr286) was similar after exercise and after 1 h of recovery, but after 4 h CaMK(Thr286) phosphorylation was higher in Caff than CHO (P < 0.05). Phosphorylation of AMP-activated protein kinase (AMPK)(Thr172) and Akt(Ser473) was similar for both treatments at all time points. We provide the first evidence that in trained subjects coingestion of large amounts of Caff (8 mg/kg BM) with CHO has an additive effect on rates of postexercise muscle glycogen accumulation compared with consumption of CHO alone.


Subject(s)
Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Dietary Carbohydrates/pharmacology , Exercise/physiology , Glycogen/biosynthesis , Muscle, Skeletal/metabolism , Adult , Anaerobic Threshold/physiology , Bicycling/physiology , Blood Glucose/metabolism , Blotting, Western , Caffeine/blood , Central Nervous System Stimulants/blood , Cross-Over Studies , Cyclic AMP-Dependent Protein Kinases/metabolism , Diet , Double-Blind Method , Exercise Test , Humans , Insulin/blood , Kinetics , Male , Muscle, Skeletal/drug effects , Oncogene Protein v-akt/metabolism , Protein Kinases/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology
4.
Eur Spine J ; 15 Suppl 3: S389-96, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16688474

ABSTRACT

The anulus fibrosus (AF) of the intervertebral disc consists of concentric sheets of collagenous matrix that is synthesised during embryogenesis by aligned disc cells. This highly organised structure may be severely disrupted during disc degeneration and/or herniation. Cell scaffolds that incorporate topographical cues as contact guidance have been used successfully to promote the healing of injured tendons. Therefore, we have investigated the effects of topography on disc cell growth. We show that disc cells from the AF and nucleus pulposus (NP) behaved differently in monolayer culture on micro-grooved membranes of polycaprolactone (PCL). Both cell types aligned to and migrated along the membrane's micro-grooves and ridges, but AF cells were smaller (or less spread), more bipolar and better aligned to the micro-grooves than NP cells. In addition, AF cells were markedly more immunopositive for type I collagen, but less immunopositive for chondroitin-6-sulphated proteoglycans than NP cells. There was no evidence of extracellular matrix (ECM) deposition. Disc cells cultured on non-grooved PCL did not show any preferential alignment at sub-confluence and did not differ in their pattern of immunopositivity to those on grooved PCL. We conclude that substratum topography is effective in aligning disc cell growth and may be useful in tissue engineering for the AF. However, there is a need to optimise cell sources and/or environmental conditions (e.g. mechanical influences) to promote the synthesis of an aligned ECM.


Subject(s)
Fibrocartilage/metabolism , Intervertebral Disc Displacement/therapy , Intervertebral Disc/metabolism , Tissue Engineering/methods , Animals , Cattle , Cell Culture Techniques/methods , Cell Proliferation , Cells, Cultured , Collagen Type I/metabolism , Extracellular Matrix/metabolism , Fibrocartilage/ultrastructure , Intervertebral Disc/ultrastructure , Intervertebral Disc Displacement/metabolism , Intervertebral Disc Displacement/physiopathology , Proteoglycans/metabolism , Tissue Engineering/trends , Tissue Transplantation/methods , Tissue Transplantation/trends
5.
EJIFCC ; 17(2): 22-27, 2006 Jul.
Article in English | MEDLINE | ID: mdl-29765276
6.
EJIFCC ; 17(2): 28-31, 2006 Jul.
Article in English | MEDLINE | ID: mdl-29765277
7.
Clin Biochem Rev ; 26(1): 33-6, 2005 Feb.
Article in English | MEDLINE | ID: mdl-16278775
SELECTION OF CITATIONS
SEARCH DETAIL
...